CD34+ Melanocyte Stem Cells: A New Path to Neuroprotection and Melanoma Insight
Official title: Characteristics and Function of CD34+ Melanocyte Stem Cells
Funded at Baltimore VA Medical Center · NIH-11191083 · Data updated 2026-11-12
A study from the Baltimore VA Medical Center explores a special skin stem cell that may help repair nerve damage and influence melanoma treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baltimore VA Medical Center NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | April 1, 2026 |
| Project end | March 31, 2030 |
| Funding year | 2026 |
| NIH project number | 1I01BX007272-01 |
| Project ID | NIH-11191083 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients with demyelinating diseases or nerve injuries who might benefit from stem-cell–based therapies in the future.
✕Less likely to help
Individuals without interest in nerve repair or melanoma-related research may see no direct benefit.
What this research studies
Researchers will study how CD34+ melanocyte stem cells in hair follicles behave, focusing on their neural crest–like properties and potential to become nerve-supporting cells. The project aims to uncover the signals that keep these cells in a flexible state and how they might be isolated and expanded for therapeutic use. If successful, findings could inform approaches to treat demyelinating conditions and improve recovery after nerve injuries, with potential implications for veterans’ health. The work may also shed light on why certain melanoma cells resist immunotherapy, guiding future strategies to overcome resistance.
Why it matters
Potential benefit: If successful, this research could lead to new ways to promote nerve repair and inform melanoma treatments.
How similar studies have gone: Prior studies have linked neural crest–like stem cells to neural differentiation and cancer resistance, but translating this to therapy remains exploratory.
Where this research is happening
-
Baltimore VA Medical Center
Baltimore, United States Active
Researchers
- Principal investigator: Hornyak, Thomas J — Baltimore VA Medical Center
- Study coordinator: Hornyak, Thomas J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.